It is possible to eliminate false positive results obtained from dead cell Vibrio.
The "Virus Screening Kit" is characterized by its very high sensitivity and 100% specificity, allowing for results to be obtained within 24 hours. It enables the classification detection of Vibrio parahaemolyticus, Vibrio vulnificus, and cholera bacteria in a single assay. Additionally, it allows for the detection of pathogenic factor genes ctx, tdh, trh1, and trh2 through dissociation curve analysis using highly homologous specific hydrolysis probes. 【Features】 ■ Very high sensitivity ■ 100% specificity ■ Results can be obtained within 24 hours ■ Classification detection of Vibrio parahaemolyticus, Vibrio vulnificus, and cholera bacteria ■ Detection of pathogenic factor genes ctx, tdh, trh1, and trh2 *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Target Samples】 ■ Fresh seafood (white shrimp, squid, raw oysters, etc.) ■ Processed seafood products (seafood dumplings, smoked salmon, etc.) ■ Processed foods (sushi, seaweed salad, etc.) ■ Vegetables *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company, BioDot Japan Co., Ltd., was established in February 2012 as the Japanese subsidiary of BioDot Inc. in the United States, and we have been supplying various diagnostic reagents and production equipment. BioDot Inc. is a venture company founded in 1994 in Irvine, California. The company’s self-developed non-contact micro-dispenser system (patented) has become the de facto standard for the development and production of immunochromatographic reagents and enzyme sensor reagents, widely used around the world. Additionally, the company has continuously commercialized peripheral devices, which have now become essential support equipment in these fields. However, we believe that in order to further advance the increasingly important clinical testing technologies, it is necessary to provide a wide range of raw materials, information, and services from both domestic and international sources, not just BioDot products. Therefore, we transformed into ForDix Co., Ltd. in December 2015. The technology for diagnostic reagents developed through clinical testing is also applied in food testing and environmental testing, supporting our lives beyond the medical field. As a company that supports those who research, develop, and commercialize these areas, we will strive to become a trusted presence.